Keybanc Maintains Overweight on Teradyne, Raises Price Target to $149
Portfolio Pulse from Benzinga Newsdesk
Keybanc analyst Steve Barger maintains an Overweight rating on Teradyne (NASDAQ:TER) and raises the price target from $140 to $149.
May 21, 2024 | 9:38 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Keybanc analyst Steve Barger maintains an Overweight rating on Teradyne and raises the price target from $140 to $149.
The raised price target and maintained Overweight rating from a reputable analyst are likely to positively influence investor sentiment and drive short-term price appreciation for Teradyne.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100